Mirae Asset Global Investments Co., Ltd. Bristol Myers Squibb CO Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,664,157 shares of BMY stock, worth $78.2 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,664,157
Previous 1,566,160
6.26%
Holding current value
$78.2 Million
Previous $88.6 Million
14.58%
% of portfolio
0.27%
Previous 0.37%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,808Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.99 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.45 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.08 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.45 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.12 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...